Claritine

Medicinal product

(Invented) name

Claritine

Active substance (s)

Loratadinas

Strength

10 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis/Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AX13, Loratadine

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2022-10-11

Date of renewal

Documents

1747_Claritine_2022-10-11.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Loratadinas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109608	95714	1095714	lizdinė plokštelė	N10		Nereceptinis	LT/L/22/1747/001	Tiekiama	-	-	No	-	-	Download
109609	95715	1095715	lizdinė plokštelė	N30		Receptinis	LT/L/22/1747/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-10-11	Registruotas